Combined Therapeutics has developed a unique modified mRNA platform which targets protein expression to specific tissues while reducing off target effects. Together with our partners, we are committed to using our platform to protect vulnerable populations from global infectious disease threats as well as to cure cancer.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 40 Guest St, Boston,massachusetts 02135,united States
- Phone
- (44) 747-050-8164
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- combinedtx.com
- Keywords
- Biotechnology, Nanotechnology, Immuno-oncology, Inflammatory diseases, mRNA, Infectious Disease, Vaccine.
- HQ
- Boston, Massachusetts
Combined Therapeutics Questions
Combined Therapeutics's helpline number is (44) 747-050-8164
Combined Therapeutics's website is combinedtx.com
Combined Therapeutics's LinkedIn profile is https://www.linkedin.com/company/combined-therapeutics
Combined Therapeutics has
12 employees.
View email and phone details for 12
employees at Combined Therapeutics.
Combined Therapeutics's industry is
Biotechnology Research
Combined Therapeutics's top competitors are
Replicate Bioscience, Inc.,
Orbital Therapeutics,
Overt Bio,
Anabios Corporation,
Cellchorus,
Excellos,
Novoron Bioscience,
Novabioassays,
Tallano Technologies,
Degroof Petercam.
Combined Therapeutics's categories are Biotechnology Research
Combined Therapeutics's founding year is 2016
